Biomedical literature mining: challenges and solutions in the 'omics' era

D Chaussabel - American Journal of Pharmacogenomics, 2004 - Springer
It is now obvious that the rate-limiting step in high throughput experimentation is neither data
acquisition nor analysis, but rather our ability to interpret data on a genome-wide scale …

[PDF][PDF] Biomedical Literature Mining

D Chaussabel - Am J Pharmacogenomics, 2004 - researchgate.net
Abstract analysis, but rather our ability to interpret data on a genome-wide scale. Indeed, the
explosion of data sampling capacity combined with increasing publication rates greatly …

Biomedical Literature Mining

D Chaussabel - American Journal of Pharmacogenomics, 2004 - infona.pl
It is now obvious that the rate-limiting step in high throughput experimentation is neither data
acquisition nor analysis, but rather our ability to interpret data on a genome-wide scale …

[PDF][PDF] Biomedical Literature Mining

D Chaussabel - Am J Pharmacogenomics, 2004 - Citeseer
Abstract analysis, but rather our ability to interpret data on a genome-wide scale. Indeed, the
explosion of data sampling capacity combined with increasing publication rates greatly …

Biomedical literature mining: challenges and solutions in the'omics' era

D Chaussabel - … in drug development and clinical practice, 2004 - pubmed.ncbi.nlm.nih.gov
It is now obvious that the rate-limiting step in high throughput experimentation is neither data
acquisition nor analysis, but rather our ability to interpret data on a genome-wide scale …

[引用][C] Biomedical literature mining: challenges and solutions in the'omics' era

D CHAUSSABEL - Am J Pharmacogenomics, 2004 - cir.nii.ac.jp

Biomedical literature mining: challenges and solutions in the'omics' era.

D Chaussabel - … : Genomics-related Research in Drug Development …, 2004 - europepmc.org
It is now obvious that the rate-limiting step in high throughput experimentation is neither data
acquisition nor analysis, but rather our ability to interpret data on a genome-wide scale …